{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:40:50Z","timestamp":1793922050037,"version":"4.8.0"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Respiratory J"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to examine the predictive effect of the lymphocyte\u2010to\u2010neutrophil ratio (LNR) and the platelet\u2010to\u2010neutrophil ratio (PNR) on the expression of programmed death receptor ligand 1 (PD\u2010L1) in patients diagnosed with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical records of 86 patients diagnosed with lung cancer between January 2020 and February 2022 at Fu Yang People's Hospital were retrospectively analyzed. The records included information on age, gender, smoking history, hematological indices at the time of admission, staging of the lung malignancy, histopathological subtype, comorbidities, and the expression levels of PD\u2010L1. Patients were stratified into two distinct cohorts based on their PD\u2010L1 expression levels: Those with an expression level greater than or equal to 1% were classified into the PD\u2010L1 positive expression group, while the remainder were categorized as the PD\u2010L1 negative expression group. Univariate analysis and multivariate logistic regression analysis were used to identify the influencing factors of PD\u2010L1, and the diagnostic efficacy was calculated using the receiver operating characteristic (ROC) curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Upon analysis, the PD\u2010L1 positive expression group manifested notably lower values as compared to their counterparts in the PD\u2010L1 negative expression group (LNR: 0.262\u2009\u00b1\u20090.105 vs. 0.390\u2009\u00b1\u20090.201; PNR: 41.03 [29.64, 50.11] vs. 49.50 [37.38, 73.83]), and these differences were statistically significant. There was a notable disparity in PD\u2010L1 expression based on gender, with males exhibiting a statistically significant higher positivity rate compared to females. Furthermore, patients in Stages I\u2013III of the disease demonstrated a markedly elevated PD\u2010L1 positivity rate compared to those in Stage IV (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Incorporating univariates with statistical differences into multivariate logistic regression analysis suggests that stage and LNR are independent risk factors for PD\u2010L1 negative expression. ROC curve analyses revealed that the area under the ROC curve (AUC) for LNR as an indicator for PD\u2010L1 positive expression stood at 0.706, while the AUC for PNR was calculated at 0.687.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PD\u2010L1 expression is correlated with gender and lung cancer staging, and LNR and PNR have a predictive value for PD\u2010L1 expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/crj.13821","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:46:42Z","timestamp":1723614402000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive Value of Lymphocyte\u2010to\u2010Neutrophil Ratio and Platelet\u2010to\u2010Neutrophil Ratio on PD\u2010L1 Expression in Lung Cancer"],"prefix":"10.1111","volume":"18","author":[{"given":"Shun\u2010Shun","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine Fuyang People's Hospital  Fuyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine Fuyang Infectious Disease Clinical College of Anhui Medical University  Fuyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2927-6120","authenticated-orcid":false,"given":"Rui\u2010Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine Fuyang People's Hospital  Fuyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"4","key":"e_1_2_11_3_1","first-page":"352","article-title":"Expressions and Clinical Significance of Programmed Death Ligand\u20101 and Tumor Mutation Burden in Esophageal Squamous Cell Carcinoma","volume":"47","author":"Li S. Y.","year":"2021","journal-title":"Jiangsu Medical Journal"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.02.006"},{"issue":"9","key":"e_1_2_11_5_1","first-page":"733","article-title":"Chinese Expert Consensus on Standards of PD\u2010L1 Immunohistochemistry Testing for Non\u2010Small Cell Lung Cancer","volume":"23","author":"Lin D. M.","year":"2020","journal-title":"Chinese Journal of Lung Cancer"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy041"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep13110"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.555"},{"issue":"2","key":"e_1_2_11_10_1","first-page":"154","article-title":"Expression and Clinical Significance of TIM\u20103, PD\u20101, PD\u2010L1 in Non\u2010Small Cell Lung Cancer","volume":"30","author":"Gao F.","year":"2019","journal-title":"Hainan Medical Journal"},{"issue":"9","key":"e_1_2_11_11_1","first-page":"623","article-title":"Correlation Study on Expression of PD\u20101 and PD\u2010L1 in Non\u2010Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations","volume":"24","author":"Jiang L.","year":"2021","journal-title":"Chinese Journal of Lung Cancer"},{"issue":"4","key":"e_1_2_11_12_1","first-page":"549","article-title":"Relationship Between the Expression of PD\u20101 and PD\u2010L1 in Tumor Tissues of Patients With Non\u2010Small Cell Lung Cancer and the Clinicopathological Parameters and Prognosis","volume":"43","author":"Ma Q.","year":"2021","journal-title":"Sichuan Journal of Physiological Sciences"},{"issue":"20","key":"e_1_2_11_13_1","first-page":"86","article-title":"Chronic Inflammation and Cancer: Paradigm on Tumor Progression, Metastasis and Therapeutic Intervention","volume":"1","author":"Khan S.","year":"2016","journal-title":"Gulf Journal of Oncology"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/2311-8571.382025"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0928-4"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00571-6"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27782"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0669-2"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.10.030"}],"container-title":["The Clinical Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/crj.13821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T05:14:09Z","timestamp":1725340449000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/crj.13821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/crj.13821"],"URL":"https:\/\/doi.org\/10.1111\/crj.13821","archive":["Portico"],"relation":{},"ISSN":["1752-6981","1752-699X"],"issn-type":[{"value":"1752-6981","type":"print"},{"value":"1752-699X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2024-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13821"}}